Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US

This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain.

Detalles Bibliográficos
Autores principales: Weiner, Scott G., Qato, Dima M., Faust, Jeremy Samuel, Clear, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220511/
https://www.ncbi.nlm.nih.gov/pubmed/37234009
http://dx.doi.org/10.1001/jamanetworkopen.2023.16089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220511/
https://www.ncbi.nlm.nih.gov/pubmed/37234009
http://dx.doi.org/10.1001/jamanetworkopen.2023.16089

Ejemplares similares